Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Licht, JD' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 55 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Zelent, A; Guidez, F; Melnick, A; Waxman, S; Licht, JD
      Translocations of the RAR alpha gene in acute promyelocytic leukemia

      ONCOGENE
    2. Licht, JD
      AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML

      ONCOGENE
    3. Srivastava, DK; Tendler, CL; Milani, D; English, MA; Licht, JD; Wilson, SH
      The HIV-1 transactivator protein Tat is a potent inducer of the human DNA repair enzyme beta-polymerase

      AIDS
    4. Licht, JD
      Targeting aberrant transcriptional repression in leukemia: a therapeutic reality?

      JOURNAL OF CLINICAL INVESTIGATION
    5. Gross, I; Bassit, B; Benezra, M; Licht, JD
      Mammalian Sprouty proteins inhibit cell growth and differentiation by preventing Ras activation

      JOURNAL OF BIOLOGICAL CHEMISTRY
    6. Zhao, F; Satoda, M; Licht, JD; Hayashizaki, Y; Gelb, BD
      Cloning and characterization of a novel mouse AP-2 transcription factor, Ap-2 gamma, with unique DNA binding and transactivation properties

      JOURNAL OF BIOLOGICAL CHEMISTRY
    7. Ward, JO; McConnell, MJ; Carlile, GW; Pandolfi, PP; Licht, JD; Freedman, LP
      The acute promyelocytic leukemia-associated protein, promyelocytic leukemia zinc finger, regulates 1,25-dihydroxyvitamin D-3-induced monocytic differentiation of U937 cells through a physical interaction with vitamin D-3 receptor

      BLOOD
    8. Melnick, AM; Westendorf, JJ; Polinger, A; Carlile, GW; Arai, S; Ball, HJ; Lutterbach, B; Hiebert, SW; Licht, JD
      The ETO protein disrupted in t(8;21)-associated acute myeloid leukemia is a corepressor for the promyelocytic leukemia zinc finger protein

      MOLECULAR AND CELLULAR BIOLOGY
    9. Melnick, A; Ahmad, KF; Arai, S; Polinger, A; Ball, H; Borden, KL; Carlile, GW; Prive, GG; Licht, JD
      In-depth mutational analysis of the promyelocytic leukemia zinc finger BTB/POZ domain reveals motifs and residues required for biological and transcriptional functions

      MOLECULAR AND CELLULAR BIOLOGY
    10. Houvras, Y; Benezra, M; Zhang, HB; Manfredi, JJ; Weber, BL; Licht, JD
      BRCA1 physically and functionally interacts with ATF1

      JOURNAL OF BIOLOGICAL CHEMISTRY
    11. Hosono, S; Gross, I; English, MA; Hajra, KM; Fearon, ER; Licht, JD
      E-cadherin is a WT1 target gene

      JOURNAL OF BIOLOGICAL CHEMISTRY
    12. Melnick, A; Carlile, GW; McConnell, MJ; Polinger, A; Hiebert, SW; Licht, JD
      AML-1/ETO fusion protein is a dominant negative inhibitor of transcriptional repression by the promyelocptic leukemia zinc finger protein

      BLOOD
    13. Yeyati, PL; Shaknovich, R; Boterashvili, S; Li, J; Ball, HJ; Waxman, S; Nason-Burchenal, K; Dmitrovsky, E; Zelent, A; Licht, JD
      Leukemia translocation protein PLZF inhibits cell growth and expression ofcyclin A

      ONCOGENE
    14. Hummel, JL; Wells, RA; Dube, ID; Licht, JD; Kamel-Reid, S
      Deregulation of NPM and PLZF in a variant t(5;17) case of acute promyelocytic leukemia

      ONCOGENE
    15. Hosono, S; Luo, X; Hyink, DP; Schnapp, LM; Wilson, PD; Burrow, CR; Reddy, JC; Atweh, GF; Licht, JD
      WT1 expression induces features of renal epithelial differentiation in mesenchymal fibroblasts

      ONCOGENE
    16. Licht, JD; Collins, K
      Telomerase RNA function in recombinant Tetrahymena telomerase

      GENES & DEVELOPMENT
    17. Melnick, A; Fruchtman, S; Zelent, A; Liu, M; Huang, Q; Boczkowska, B; Calasanz, MJ; Fernandez, A; Licht, JD; Najfeld, V
      Identification of novel chromosomal rearrangements in acute myelogenous leukemia involving loci on chromosome 2p23, 15q22 and 17q21

      LEUKEMIA
    18. van Schothorst, EM; Prins, DEM; Baysal, BE; Beekman, M; Licht, JD; Waxman, S; Zelent, A; Cornelisse, CJ; van Ommen, GJB; Richard, CW; Devilee, P
      Genomic structure of the human PLZF gene

      GENE
    19. Ball, HJ; Melnick, A; Shaknovich, R; Kohanski, RA; Licht, JD
      The promyelocytic leukemia zinc finger (PLZF) protein binds DNA in a high molecular weight complex associated with cdc2 kinase

      NUCLEIC ACIDS RESEARCH
    20. English, MA; Licht, JD
      Tumor-associated WT1 missense mutants indicate that transcriptional activation by WT1 is critical for growth control

      JOURNAL OF BIOLOGICAL CHEMISTRY
    21. Hoatlin, ME; Zhi, Y; Ball, H; Silvey, K; Melnick, A; Stone, S; Arai, S; Hawe, N; Owen, G; Zelent, A; Licht, JD
      A novel BTB/POZ transcriptional repressor protein interacts with the Fanconi anemia group C protein and PLZF

      BLOOD
    22. Melnick, A; Licht, JD
      Deconstructing a disease: RAR alpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia

      BLOOD
    23. SHAKNOVICH R; YEYATI PL; IVINS S; MELNICK A; LEMPERT C; WAXMAN S; ZELENT A; LICHT JD
      THE PROMYELOCYTIC LEUKEMIA ZINC-FINGER PROTEIN AFFECTS MYELOID CELL-GROWTH, DIFFERENTIATION, AND APOPTOSIS

      Molecular and cellular biology
    24. HANNAROSE W; LICHT JD; HANSEN U
      2 EVOLUTIONARILY CONSERVED REPRESSION DOMAINS IN THE DROSOPHILA KRUPPEL PROTEIN DIFFER IN ACTIVATOR SPECIFICITY

      Molecular and cellular biology
    25. SOMASUNDARAM K; ZHANG HB; ZENG YX; HOUVRAS Y; PENG Y; ZHANG HX; WU GS; LICHT JD; WEBER BL; ELDEIRY WS
      ARREST OF THE CELL-CYCLE BY THE TUMOR-SUPPRESSOR BRCA1 REQUIRES THE CDK-INHIBITOR P21(WAF1 CIP1)/

      Nature
    26. LI JY; ENGLISH MA; BALL HJ; YEYATI PL; WAXMAN S; LICHT JD
      SEQUENCE-SPECIFIC DNA-BINDING AND TRANSCRIPTIONAL REGULATION BY THE PROMYELOCYTIC LEUKEMIA ZINC-FINGER PROTEIN

      The Journal of biological chemistry
    27. TENEN DG; HROMAS R; LICHT JD; ZHANG DE
      TRANSCRIPTION FACTORS, NORMAL MYELOID DEVELOPMENT, AND LEUKEMIA

      Blood
    28. YEYATI PL; SHAKNOVICH R; WAXMAN S; ZELENT A; LICHT JD
      THE RAR-ALPHA-PLZF PROTEIN GENERATED IN T(11Q23-17)-ASSOCIATED ACUTE PROMYELOCYTIC LEUKEMIA DISPLAYS ONCOGENIC PROPERTIES

      Blood
    29. BALL HJ; LI JY; ZELENT A; WAXMAN S; LICHT JD
      BINDING OF THE PROMYELOCYTIC LEUKEMIA ZINC-FINGER (PLZF) PROTEIN TO AGENOMIC BINDING-SITE IS MODULATED BY THE CONSERVED POZ DOMAIN AND PHOSPHORYLATION

      Blood
    30. LICHT JD; SHAKNOVICH R; ENGLISH MA; MELNICK A; LI JY; REDDY JC; DONG S; CHEN SJ; ZELENT A; WAXMAN S
      REDUCED AND ALTERED DNA-BINDING AND TRANSCRIPTIONAL PROPERTIES OF THEPLZF-RETINOIC ACID RECEPTOR-ALPHA CHIMERA GENERATED IN T(11-17)-ASSOCIATED ACUTE PROMYELOCYTIC LEUKEMIA

      Oncogene
    31. JOHNSTONE RW; SEE RH; SELLS SF; WANG J; MUTHUKKUMAR S; ENGLERT C; HABER DA; LICHT JD; SUGRUE SP; ROBERTS T; RANGNEKAR VM; SHI Y
      A NOVEL REPRESSOR, PAR-4, MODULATES TRANSCRIPTION AND GROWTH SUPPRESSION FUNCTIONS OF THE WILMS-TUMOR SUPPRESSOR WT1

      Molecular and cellular biology
    32. YEYATI PL; SHAKNOVICH R; ZELENT A; LI J; WAXMAN S; LICHT JD
      CYCLIN-A IS A CANDIDATE TARGET GENE FOR THE PROMYELOCYTIC LEUKEMIA ZINC-FINGER PROTEIN

      Blood
    33. SHAKNOVICH R; YEYATI PL; WAXMAN S; HELLINGER N; NASONBURCHENAL K; DMITROVSKY E; STRUTT P; ZELENT A; LICHT JD
      THE PROMYELOCYTIC LEUKEMIA ZINC-FINGER PROTEIN (PLZF) SUPPRESSES GROWTH AND INDUCES APOPTOSIS IN THE 32DCL3 MYELOID CELL-LINE

      Blood
    34. BALL HJ; LI JY; ZELENT A; WAXMAN S; LICHT JD
      SELECTION OF DNA-SEQUENCES BINDING THE PROMYELOCYTIC LEUKEMIA ZINC-FINGER PROTEIN FROM A CPG ISLAND GENOMIC LIBRARY

      Blood
    35. LUO XN; REDDY JC; YEYATI PL; IDRIS AH; HOSONO S; HABER DA; LICHT JD; ATWEH GF
      THE TUMOR-SUPPRESSOR GENE WT1 INHIBITS RAS-MEDIATED TRANSFORMATION

      Oncogene
    36. LICHT JD; SHAKNOVICH R; ENGLISH MA; MELNICK A; LI JY; WEILAND S; TARCSAFALVI A; WAXMAN S
      THE CHIMERIC PLZF-RAR-ALPHA FUSION PROTEIN OF T(11-17) ASSOCIATED ACUTE PROMYELOCYTIC LEUKEMIA IS AN ABERRANT RAR THAT INTERFERES WITH WILD-TYPE RAR-ALPHA FUNCTION

      Journal of cellular biochemistry
    37. REDDY JC; HOSONO S; LICHT JD
      THE TRANSCRIPTIONAL EFFECT OF WT1 IS MODULATED BY CHOICE OF EXPRESSION VECTOR

      The Journal of biological chemistry
    38. REDDY JC; MORRIS JC; WANG J; ENGLISH MA; HABER DA; SHI Y; LICHT JD
      WT1-MEDIATED TRANSCRIPTIONAL ACTIVATION IS INHIBITED BY DOMINANT-NEGATIVE MUTANT PROTEINS

      The Journal of biological chemistry
    39. SHAKNOVICH R; WEINBERG RS; ZELENT A; REED A; STRUTT P; WAXMAN S; LICHT JD
      THE PROMYELOCYTIC LEUKEMIA ZINC-FINGER PROTEIN HAS GROWTH SUPPRESSIVEACTIVITY DISRUPTED IN T(11-17) ASSOCIATED APL

      Blood
    40. LI JY; YEYATI P; ZELENT A; CHEN Z; CHEN SJ; WAXMAN S; LICHT JD
      DNA-BINDING AND TRANSCRIPTION REGULATION BY THE PROMYELOCYTIC LEUKEMIA ZINC-FINGER (PLZF) PROTEIN

      Blood
    41. LICHT JD; CHOMIENNE C; GOY A; CHEN A; SCOTT AA; HEAD DR; MICHAUX JL; WU Y; DEBLASIO A; MILLER WH; ZELENETZ AD; WILLMAN CL; CHEN Z; CHEN SJ; ZELENT A; MACINTYRE E; VEIL A; CORTES J; KANTARJIAN H; WAXMAN S
      CLINICAL AND MOLECULAR CHARACTERIZATION OF A RARE SYNDROME OF ACUTE PROMYELOCYTIC LEUKEMIA ASSOCIATED WITH TRANSLOCATION (11-17)

      Blood
    42. LICHT JD; MAZANET R; LOEHRER PJ; GONIN R; ANTMAN KH
      PHASE-IV TRIAL OF DAILY ORAL ETOPOSIDE IN THE TREATMENT OF ADVANCED SOFT-TISSUE SARCOMA

      Cancer chemotherapy and pharmacology
    43. LICHT JD; HANNAROSE W; REDDY JC; ENGLISH MA; RO M; GROSSEL M; SHAKNOVICH R; HANSEN U
      MAPPING AND MUTAGENESIS OF THE AMINO-TERMINAL TRANSCRIPTIONAL REPRESSION DOMAIN OF THE DROSOPHILA KRUPPEL PROTEIN

      Molecular and cellular biology
    44. MELNICK AM; ENGLISH MA; SHAKNOVICH R; CHEN Z; ZELENT A; WAXMAN S; LICHT JD
      ALTERED DNA-BINDING ACTIVITY OF THE RETINOIC ACID RECEPTOR-ALPHA (RAR-ALPHA) WHEN FUSED TO THE PLZF PROTEIN IN T(11-17) ACUTE PROMYELOCYTICLEUKEMIA (APL)

      Clinical research
    45. CHEN A; LICHT JD; WU Y; HELLINGER N; SCHER W; WAXMAN S
      RETINOIC ACID IS REQUIRED FOR AND POTENTIATES DIFFERENTIATION OF ACUTE PROMYELOCYTIC LEUKEMIA-CELLS BY NONRETINOID AGENTS

      Blood
    46. LI JY; ENGLISH MA; BISHT S; WAXMAN S; LICHT JD
      DNA-BINDING AND TRANSCRIPTION REGULATION BY THE PROMYELOCYTIC LEUKEMIA ZINC-FINGER PROTEIN

      Blood
    47. ZELENT A; COOK M; GOULD A; REID A; LICHT JD; SHAKNOVICH R; LI JY; DAVIES J; STRUTT P; WAXMAN S; KRUMLAUF R
      DEVELOPMENTAL EXPRESSION OF THE MURINE HOMOLOG OF THE PROMYELOCYTIC LEUKEMIA ZINC-FINGER GENE

      Blood
    48. LICHT JD; CHOMIENNE C; GOY A; CHEN A; SCOTT AA; HEAD DR; MICHAUX JL; WU Y; DEBLASIO A; MILLER WH; ZELENETZ AD; WILLMAN CL; CHEN Z; CHEN SJ; ZELENT A; MACINTYRE E; VEIL A; CORTES J; KANTARJIAN H; WAXMAN S
      ACUTE PROMYELOCYTIC LEUKEMIA ASSOCIATED WITH T(1117) IS A DISCRETE SYNDROME THAT FAILS TO RESPOND TO RETINOIC ACID

      Blood
    49. SHAKNOVICH R; ENGLISH MA; MELNICK A; LI JY; WEILAND S; TARCSAFALVI A; WAXMAN S; LICHT JD
      THE CHIMERIC PLZF-RAR-ALPHA FUSION PROTEIN OF T(11-17) APL IS AN ABERRANT RAR THAT INTERFERES WITH WILD-TYPE RAR-ALPHA FUNCTION

      Blood
    50. SCOTT AA; HEAD DR; KOPECKY KJ; APPELBAUM FR; THEIL KS; GREVER MR; CHEN IM; WHITTAKER MH; GRIFFITH BB; LICHT JD; WAXMAN S; WHALEN MM; BANKHURST AD; RICHTER LC; GROGAN TM; WILLMAN CL
      HLA-DR-, CD33- MYELOID(, CD56+, CD16)NATURAL KILLER-CELL ACUTE-LEUKEMIA - A PREVIOUSLY UNRECOGNIZED FORM OF ACUTE-LEUKEMIA POTENTIALLY MISDIAGNOSED AS FRENCH-AMERICAN-BRITISH ACUTE MYELOID LEUKEMIA-M3/

      Blood
    51. LICHT JD; RO M; ENGLISH MA; GROSSEL M; HANSEN U
      SELECTIVE REPRESSION OF TRANSCRIPTIONAL ACTIVATORS AT A DISTANCE BY THE DROSOPHILA KRUPPEL PROTEIN

      Proceedings of the National Academy of Sciences of the United Statesof America
    52. CHEN Z; LICHT JD; ZELENT A; CHEN SJ; CHEN A; WU Y; MILLER WH; ZELENETZ A; GOY A; DEBLASIO A; SCOTT A; WILLMAN C; HEAD D; CHOMIENNE C; GUIDEZ F; WAXMAN S
      CLINICAL AND MOLECULAR CHARACTERIZATION OF THE ACUTE PROMYELOCYTIC LEUKEMIA (APL) ASSOCIATED WITH T(11, 17) AND PLZF-RAR-ALPHA FUSION

      Blood
    53. LICHT JD; CHEN Z; ZELENT A; CHEN SJ; CHEN A; LI J; WU Y; MELNICK A; SHAKNOVICH R; ENGLISH MA; WAXMAN S
      FUNCTIONAL-CHARACTERIZATION OF THE PROMYELOCYTIC LEUKEMIA ZINC-FINGER(PLZF) PROTEIN AND ITS FUSION PROTEINS WITH RAR-ALPHA

      Blood
    54. REDDY JC; MORRIS JC; ENGLISH MA; HABER DA; LUO XN; ATWEH G; LICHT JD
      THE WILMS-TUMOR (WT1) GENE-PRODUCT BOTH ACTIVATES AND REPRESSES TRANSCRIPTION

      Blood
    55. DEFRANCO C; RO M; GROSSEL M; ENGLISH MA; HANSEN UM; WAGNER JA; LICHT JD
      NGFIA (EGR1) CONTAINS TRANSCRIPTION ACTIVATING DOMAINS IN BOTH THE AMINO-TERMINAL AND CARBOXYL-TERMINAL REGIONS OF THE PROTEIN

      Biochemical and biophysical research communications


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/10/20 alle ore 15:55:56